Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126689201 | 12668920 | 1 | I | 20160809 | 20160819 | 20160819 | EXP | CH-009507513-1608CHE005591 | MERCK | 80.00 | YR | M | Y | 0.00000 | 20160819 | CN | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126689201 | 12668920 | 1 | PS | REMERON | MIRTAZAPINE | 1 | Oral | 1 DF, QD | 20415 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126689201 | 12668920 | 1 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126689201 | 12668920 | HO |
| 126689201 | 12668920 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126689201 | 12668920 | Constipation | |
| 126689201 | 12668920 | Dizziness | |
| 126689201 | 12668920 | Hallucination | |
| 126689201 | 12668920 | Headache | |
| 126689201 | 12668920 | Insomnia | |
| 126689201 | 12668920 | Muscle spasms | |
| 126689201 | 12668920 | Parkinson's disease | |
| 126689201 | 12668920 | Product use issue | |
| 126689201 | 12668920 | Restless legs syndrome | |
| 126689201 | 12668920 | Tremor | |
| 126689201 | 12668920 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |